TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/15/23 16:28 | 6/14/23 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cooper Warren D | PA | D | S.d | 0 | 0.3481 | 0 | 0 | 0 | 76 | D | |||||||||||||||
6/16/22 21:49 | 6/14/22 | ZYNE | Zynerba Pharmaceuticals, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Cooper Warren D | PA | D | S.d | 0 | 1.01 | 0 | 0 | 0 | 28 | D | |||||||||||||||
7/8/08 14:30 | 7/7/08 | NXXI | Nutrition 21 Inc | NY | Health | BioPrd | Biological Products, (No Diag | Cooper Warren D | NY | D | P | 9 | 0.3500 | 0 | 25 | 250 | 35 | D | |||||||||||||||
10/16/07 10:43 | 10/15/07 | NXXI | Nutrition 21 Inc | NY | Health | BioPrd | Biological Products, (No Diag | Cooper Warren D | NY | D | P | 8 | 0.8200 | 0 | 10 | New | 10 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |